191 related articles for article (PubMed ID: 15868995)
1. [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].
Hendrix Y; van Zagten MS
Ned Tijdschr Geneeskd; 2005 Apr; 149(16):888-90. PubMed ID: 15868995
[TBL] [Abstract][Full Text] [Related]
2. [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].
le Comte M; Wensveen B
Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1654; author reply 1654. PubMed ID: 16078777
[No Abstract] [Full Text] [Related]
3. Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
Koran LM; Pallanti S; Quercioli L
Eur Neuropsychopharmacol; 2001 Apr; 11(2):169-72. PubMed ID: 11313163
[TBL] [Abstract][Full Text] [Related]
4. A surfeit of serotonin: sumatriptan and serotonergic antidepressants.
Schwartz CE
Arch Intern Med; 1999 May; 159(10):1141-2. PubMed ID: 10335694
[No Abstract] [Full Text] [Related]
5. [Combination of serotonergic agents resulted in severe adverse effects].
Jägestedt M; von Bahr C
Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539
[TBL] [Abstract][Full Text] [Related]
6. Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline.
Wu ML; Deng JF
J Chin Med Assoc; 2009 Aug; 72(8):446-9. PubMed ID: 19687003
[TBL] [Abstract][Full Text] [Related]
7. Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.
Boutilier AS; Gardner DM
J Clin Pharm Ther; 2003 Feb; 28(1):69-72. PubMed ID: 12605621
[No Abstract] [Full Text] [Related]
8. Effect of chronic paroxetine treatment on 5-HT1B and 5-HT1D autoreceptors in rat dorsal raphe nucleus.
Davidson C; Stamford JA
Neurochem Int; 2000 Feb; 36(2):91-6. PubMed ID: 10676872
[TBL] [Abstract][Full Text] [Related]
9. Serotonin syndrome complicating migraine pharmacotherapy.
Mathew NT; Tietjen GE; Lucker C
Cephalalgia; 1996 Aug; 16(5):323-7. PubMed ID: 8869767
[TBL] [Abstract][Full Text] [Related]
10. Serotonin syndrome: case report and review of the literature.
Weiner AL; Tilden FF; McKay CA
Conn Med; 1997 Nov; 61(11):717-21. PubMed ID: 9419960
[TBL] [Abstract][Full Text] [Related]
11. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
[TBL] [Abstract][Full Text] [Related]
12. Facial flushing: an uncommon presentation of serotonin toxicity.
Deng M; Nedorost S
Dermatitis; 2009; 20(5):296-7. PubMed ID: 19808008
[No Abstract] [Full Text] [Related]
13. Hyponatremia upon resumption of paroxetine therapy.
Wakita M; Matsuoka H; Hamada R; Okatsu H; Nakajima T; Osame M
Intern Med; 2005 Mar; 44(3):240-2. PubMed ID: 15805714
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder.
Takahashi T; Mitsuya H; Murata T; Murayama J; Wada Y
Sleep Med; 2008 Mar; 9(3):317-9. PubMed ID: 17644482
[TBL] [Abstract][Full Text] [Related]
15. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
Duncan MJ; Hensler JG
Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
[TBL] [Abstract][Full Text] [Related]
16. A 70-Year-Old Woman Presenting with Confusion and Muscle Spasms Due to Serotonin Syndrome Associated with Paroxetine and Quetiapine Treatment.
Mostel E; Patel S; Wiener BG
Am J Case Rep; 2022 Nov; 23():e938268. PubMed ID: 36366736
[TBL] [Abstract][Full Text] [Related]
17. Serotonin syndrome and the use of SSRIs.
Finfgeld DL
J Psychosoc Nurs Ment Health Serv; 2004 Feb; 42(2):16-20. PubMed ID: 14982105
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Goldstein D
Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
[No Abstract] [Full Text] [Related]
19. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
Redrobe JP; Bourin M; Colombel MC; Baker GB
J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of fluoxetine and sumatriptan: the Canadian experience.
Joffe RT; Sokolov ST
Acta Psychiatr Scand; 1997 Jun; 95(6):551-2. PubMed ID: 9242852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
